Brn3a expression is epigenetically controlled by HDAC2 in melanocytes and melanoma

Heppt M, Wessely A, Hornig E, Kammerbauer C, Graf S, Besch R, French LE, Kuphal S, Kappelmann-Fenzl M, Boßerhoff AK, Berking C (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Experimental Dermatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: E96-E96

Conference Proceedings Title: EXPERIMENTAL DERMATOLOGY

Authors with CRIS profile

Markus Heppt Department of Dermatology Silke Kuphal Medizinische Fakultät Melanie Kappelmann-Fenzl Lehrstuhl für Biochemie und Molekulare Medizin Anja Katrin Boßerhoff Lehrstuhl für Biochemie und Molekulare Medizin Carola Berking Lehrstuhl für Haut- und Geschlechtskrankheiten

Involved external institutions

Universitätsklinikum der Ludwig-Maximilians-Universität München DE Germany (DE)

How to cite

APA:

Heppt, M., Wessely, A., Hornig, E., Kammerbauer, C., Graf, S., Besch, R.,... Berking, C. (2021). Brn3a expression is epigenetically controlled by HDAC2 in melanocytes and melanoma. In EXPERIMENTAL DERMATOLOGY (pp. E96-E96). HOBOKEN: WILEY.

MLA:

Heppt, Markus, et al. "Brn3a expression is epigenetically controlled by HDAC2 in melanocytes and melanoma." Proceedings of the EXPERIMENTAL DERMATOLOGY HOBOKEN: WILEY, 2021. E96-E96.

BibTeX: Download